Wafergen BioSystems Raises $1.3M in Stock Placement | GenomeWeb
NEW YORK (GenomeWeb News) — Wafergen BioSystems said today it has landed $1.3 million in a private placement of common stock.
 
Wafergen last week said it had gained $10.7 million in financing as it completed a reverse merger with a shell company.
  
The company said last week it plans to use the proceeds from the investment for corporate infrastructure and product offerings, such as the company’s SmartChip system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.